Cartus Chan
Principal @ HarbourVest Partners
Cartus Chan is a Principal at HarbourVest Partners. He attended The University of Chicago Booth School of Business.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Cartus Chan invests in
Stages Cartus Chan invests in
Countries Cartus Chan invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Pharmaceutical 2 (67%)
- Education 1 (33%)
- Health Care 1 (33%)
- Outsourcing 1 (33%)
- Biotechnology 1 (33%)
Stage
- Private Equity 2 (67%)
- Funding Round 1 (33%)
Country
- India 1 (33%)
- Australia 1 (33%)
- United States 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Ascender is the payroll and learning outsourcing provider. | $77.1M / Private Equity / Dec 21, 2017 | ||
| “Albany Molecular Research Inc. provides scientific services, products and technologies that improve quality of life while delivering excellence, value and maximum return.”Albany Molecular Research, Inc. (NASDAQ: AMRI) is a global contract research and manufacturing organization offering customers fully integrated drug discovery, development, andmanufacturing services. | Jan 01, 2012 | ||
| Mankind Pharma aspires to aid the community in a healthy life by formulating, developing, commercializing, and delivering affordable and accessible medicines that satisfy urgent medical needs. Mankind Pharma came into existence in 1986, and in 1991, the company was formed into a legal corporation. However, it actively started working as afully-integrated pharmaceutical company in 1995. Today, Mankind has an employee base of over 14,000 and is racing towards $1 Billion.The company takes great pride in the success of its products ranging from Pharma, OTC, and FMCG brands like Manforce Condoms, Manforce Tablets, Manforce Staylong Gel, Unwanted 72, Prega News, Adiction, Gas-O-Fast, Kaloree 1 and many others. | $24M / Private Equity / Apr 30, 2007 |
Co-Investors
About HarbourVest Partners
HarbourVest is an independent investment firm that provides innovative private equity solutions to institutional clients worldwide. As one of the first private equity fund-of-funds, they have a long and distinguished history of investing in venture, buyout, and mezzanine and distressed markets in the U.S., Europe, Asia Pacific, and emergingmarkets through primary partnerships, secondary purchases, and direct investments.
HarbourVest Partners Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Cartus Chan
Principal
|
|||
Corentin Du Roy
Managing Director & Direct Investments
|
|||
John Nelson
Fund Controller
|
|||
Kapil Kirpalani
Vice President, Legal and Compliance Officer
|
|||
Peter Lipson
Managing Director, Boston
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Cartus Chan invest in?
Cartus Chan invests primarily in Pharmaceutical, Education and Health Care startups, most often at Private Equity and Funding Round stage. Most of the 3 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Cartus Chan?
Public channels for Cartus Chan include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Cartus Chan last invest?
The most recent investment recorded for Cartus Chan closed in Dec 2017. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
